seafood
musculu
senhousei
show
antiinfluenza
viru
activ
target
virion
envelop
lipid
biochem
pharmacolog
doi
http
doi
marin
environ
known
new
sourc
structur
divers
bioactiv
molecul
paper
identifi
porphyrin
deriv
pyropheophorbid
ppa
mussel
musculu
senhousei
senhousei
show
broad
antiinfluenza
viru
activ
vitro
panel
influenza
viral
strain
analysi
mechan
action
indic
ppa
function
earli
stage
viru
infect
interact
lipid
bilay
virion
result
alter
membraneassoci
function
therebi
block
entri
envelop
virus
host
cell
addit
antiinfluenza
viru
activ
ppa
assess
mice
infect
influenza
viru
surviv
rate
mean
surviv
time
mice
appar
prolong
compar
control
group
treat
drug
therefor
ppa
deriv
may
repres
lead
compound
control
influenza
viru
infect
keyword
marin
food
musculu
senhousei
pyropheophorbid
antiinfluenza
viru
activ
envelop
viru
pseudotyp
viru
screen
approach
identifi
tradit
chines
seafood
senhousei
show
good
inhibitori
activ
toward
influenza
viru
iav
preliminari
mechanist
studi
indic
antivir
activ
food
result
inhibit
viru
entri
earli
infect
investig
bioactiv
compon
mussel
use
bioassayguid
approach
porphyrin
deriv
name
pyropheophorbid
ppa
show
signific
antiiav
activ
vitro
isol
identifi
indic
potenti
applic
molecul
develop
new
antivir
agent
iav
envelop
virus
viral
envelop
deriv
portion
host
cell
membran
function
cover
capsid
protect
packag
viral
genom
addit
lipid
bilay
viral
envelop
also
contain
viral
glycoprotein
hemagglutinin
ha
neuraminidas
na
viral
protein
compon
includ
lipid
bilay
associ
protein
play
import
role
process
viral
infect
result
view
promis
tool
develop
new
antiinfluenza
drug
ha
glycoprotein
consist
two
subunit
locat
surfac
envelop
respons
bind
receptor
site
host
membran
mediat
fusion
viral
host
membran
follow
fusion
viral
genom
abl
enter
subsequ
infect
host
cell
lipid
bilay
major
compon
iav
envelop
date
number
molecul
target
virion
envelop
lipid
interfer
fusion
viralhost
cellular
membran
report
molecul
convey
antivir
effect
biophys
mechan
due
molecular
shape
amphipath
therebi
inhibit
format
neg
curvatur
envelop
lipid
bilay
consequ
compound
show
broad
antivir
activ
toward
mani
unrel
envelop
virus
similarli
studi
identifi
compound
ppa
display
antiiav
activ
earli
stage
viru
entri
experiment
data
indic
ppa
mainli
act
ha
glycoprotein
subunit
instead
show
strong
tendenc
interact
envelop
lipid
thu
suggest
fusion
viral
cellular
membran
might
interrupt
follow
interact
ppa
viral
envelop
lipid
herein
report
antiiav
activ
possibl
mechan
action
ppa
materi
method
nmr
spectroscop
data
acquir
cdcl
solut
macklin
china
mhz
h
mhz
c
respect
bruker
spectromet
chemic
shift
referenc
correspond
solvent
residu
signal
cdcl
lowresolut
esim
record
use
water
singlequadrupol
mass
spectromet
silica
gel
mesh
qingdao
marin
chemic
factori
china
sephadex
amersham
pharmacia
biotech
reversephas
silica
gel
merck
use
column
chromatographi
madin
darbi
canin
kidney
mdck
cell
cultur
dulbecco
modifi
eagl
medium
dmem
sigma
usa
supplement
fetal
bovin
serum
fb
sigma
usa
penicillinstreptomycin
influenza
subtyp
includ
pharmacoth
pp
kentaro
kei
f
shunichi
effici
twoelectron
reduct
dioxygen
hydrogen
peroxid
oneelectron
reduct
small
overpotenti
catalyz
cobalt
chlorin
complex
pyropheophorbid
ppa
isol
seafood
senhousei
ppa
show
potent
activ
broad
panel
influenza
viral
strain
musculu
senhousei
tradit
chines
seafood
wide
distribut
pacif
coast
includ
usa
australia
japan
china
among
countri
mussel
report
live
region
rang
intertid
shallow
subtid
zone
depth
approxim
toler
low
salin
low
oxygen
level
life
span
ca
two
year
http
wwwexoticsguideorgmusculistasenhousia
outsid
shell
senhousei
smooth
shini
yellowgreen
color
grow
maximum
length
mm
interior
purplishgray
analys
habitat
growth
condit
indic
senhousei
passiv
filterfeed
shellfish
thu
addit
small
number
protozoa
main
compon
food
diatom
belong
differ
genera
marin
environ
long
view
major
reservoir
bioactiv
molecul
potenti
develop
therapeut
drug
continu
search
antiinfluenza
viral
compound
natur
sourc
use
mous
adjust
strain
apuerto
mutat
propag
chick
embryo
allanto
fluid
contain
virus
store
quantifi
tissu
cultur
infecti
dose
tcid
test
need
fresh
mussel
kg
ground
repeatedli
extract
least
three
time
etoh
l
room
temperatur
etoh
extract
evapor
reduc
pressur
afford
dark
brown
semisolid
g
suspend
water
partit
sequenti
petroleum
ether
g
dichloromethan
g
etoac
g
portion
etoac
fraction
g
subject
silica
gel
column
chromatographi
elut
gradient
petroleum
ether
etoac
yield
three
fraction
fr
activ
fraction
elut
gradient
mixtur
ch
cl
meoh
afford
anoth
three
fraction
fr
fr
purifi
reversedphas
silica
gel
eluent
ch
cn
meoh
h
afford
ppa
mg
dark
green
solid
cytotox
ppa
mdck
cell
evalu
mtt
assay
describ
briefli
mdck
cell
prepar
plate
x
cell
well
h
expos
ppa
serial
dilut
incub
h
mtt
sigma
usa
solut
mgml
dmem
diluent
ad
left
h
subsequ
supernat
remov
dmso
solut
ad
plate
dissolv
formazan
product
absorb
well
measur
nm
use
multiskan
fc
micropl
reader
thermo
fisher
scientif
massachusett
usa
mdck
cell
atcc
cultur
plate
cellswel
h
seri
doubledilut
ppa
solut
preincub
tcid
viru
min
cell
incub
viruscompound
mixtur
h
two
wash
pb
tpcktrypsin
trypsin
treat
tpck
sigma
usa
serumfre
dmem
ad
cell
next
cell
viabil
measur
use
mtt
method
h
infect
skkwk
use
posit
control
experi
independ
repeat
least
three
time
viru
subtyp
mouseadapt
strain
apuerto
apuerto
mutat
select
evalu
antivir
effect
ppa
assay
process
report
previous
briefli
cellswel
seed
plate
overnight
start
assay
viru
moi
preincub
gradient
dilut
ppa
min
mixtur
transfer
cell
incub
anoth
h
incub
cell
wash
pb
ad
fresh
medium
h
cell
supernat
collect
subject
viral
rna
isol
qrtpcr
perform
measur
express
gene
gener
serial
dilut
ppa
fb
dmem
incub
plaqu
form
unit
pfu
rsv
strain
equal
volum
fb
dmem
hour
mixtur
ad
well
plate
seed
cell
near
confluenc
plate
incub
hour
replac
mixtur
methylcellulos
dmem
five
day
later
methylcellulos
medium
thoroughli
remov
cell
fix
formaldehyd
permeabil
triton
block
nonfatmilk
mous
antisera
rsv
fusion
protein
dilut
w
incub
cell
hour
wash
three
time
tween
cell
incub
second
antibodyconjug
horseradish
peroxidas
catalogu
number
proteintech
china
hour
room
temperatur
wash
three
time
usual
final
plaqu
appear
min
later
ad
reagent
plaqu
well
manual
count
nocompound
well
made
control
test
four
differ
drug
administr
protocol
use
studi
assess
possibl
mechan
ppa
describ
previou
studi
mdck
cell
cultur
plate
cellswel
h
antivir
effect
evalu
use
two
drug
treatment
approach
infect
pretreat
viru
mention
treatment
cell
wash
pb
remov
free
viru
cultur
ml
serumfre
mem
contain
tpcktrypsin
agar
h
mention
cell
fix
paraformaldehyd
min
incub
wv
crystal
violet
dye
solut
h
effect
ppa
viral
plaqu
format
determin
count
number
plaqu
mdck
cell
cultur
plate
x
cell
well
subject
two
mode
drug
treatment
infect
pretreat
viru
h
postinfect
total
cellular
rna
extract
trizol
reagent
sigma
st
loui
mo
usa
revers
transcrib
cdna
use
primer
list
realtim
quantit
pcr
perform
use
twostep
pcr
amplif
standard
procedur
system
appli
biosystem
massachusett
usa
glyceraldehyd
dehydrogenas
gapdh
sigma
usa
use
intern
control
rel
express
ha
gene
measur
classic
method
use
softwar
sampl
test
independ
three
time
primer
sequenc
target
gene
gapdhrevers
studi
phase
viru
life
cycl
ppa
interact
infect
mdck
cell
treat
ppa
indic
time
interv
h
cover
first
viral
replic
cycl
h
cell
frozen
thaw
three
time
cell
complet
disrupt
supernat
collect
cell
debri
remov
centrifug
viru
titer
determin
method
measur
tcid
viru
polykaryon
format
inhibit
assay
perform
use
protocol
describ
nm
effect
ppa
interact
lipid
investig
measur
fluoresc
intens
briefli
lipid
suspend
pb
concentr
mgml
incub
ppa
dark
h
fluoresc
emiss
spectrum
detect
use
fluoresc
spectrophotomet
compar
sampl
lack
lipid
lipid
extract
mdck
cell
dissolv
dmso
concentr
subsequ
mice
oral
administ
differ
agent
day
five
day
sixth
day
mice
provid
access
food
water
ad
libitum
bodi
weight
mortal
gener
behavior
mice
record
daili
consecut
day
use
protocol
vivo
antiinfluenza
viru
test
describ
intragastr
administr
stop
three
mice
group
fourth
day
infect
viru
anim
sacrif
lung
harvest
wash
normal
salin
dri
gauz
weigh
lung
index
calcul
use
follow
equat
lung
index
lung
weight
bodi
weight
evalu
lung
index
lung
tissu
obtain
mice
immers
paraformaldehyd
solut
pfa
leagen
soon
possibl
lung
tissu
embed
paraffin
cut
thin
section
thick
stain
use
hematoxylin
eosin
stain
method
histopatholog
analysi
microscop
statist
perform
use
graphpad
prism
softwar
san
diego
ca
data
express
mean
standard
deviat
sd
repeat
least
three
time
imagej
use
quantiz
fluoresc
imag
data
determin
oneway
anova
use
spss
softwar
mortal
rate
analyz
logrank
mantelcox
test
p
use
graphpad
prism
softwar
statist
signific
defin
p
p
p
mussel
senhousei
collect
area
south
china
sea
guangdong
provinc
china
fresh
mussel
ground
extract
ethanol
least
three
time
crude
extract
isol
purifi
use
propano
acid
also
name
pyropheophorbid
ppa
shown
fig
fig
test
antivir
activ
addit
mtt
assay
perform
evalu
cytotox
test
molecul
determin
whether
antiiav
activ
result
cytotox
ppa
shown
tabl
cc
valu
ppa
valu
much
higher
viral
inhibitori
activ
antiiav
activ
ppa
next
confirm
use
plaqu
reduct
assay
indic
fig
quantifi
use
imagej
softwar
fig
green
fluoresc
associ
np
express
significantli
decreas
compar
viru
group
without
drug
treatment
notabl
pretreat
group
show
greater
activ
drug
simultan
treatment
group
infect
similar
conclus
obtain
measur
mrna
level
ha
gene
influenza
treatment
ppa
use
two
drug
administr
approach
fig
level
ha
gene
dramat
decreas
treat
ppa
compar
group
without
drug
treatment
p
ha
level
observ
cell
subject
pretreat
viru
lower
cell
subject
infect
treatment
furthermor
antivir
activ
ppa
also
assess
test
virus
induc
respiratori
diseas
includ
respiratori
syncyti
viru
rsv
sever
acut
respiratori
syndrom
coronaviru
indict
fig
ppa
inhibit
format
rsv
plaqu
detect
immunobas
plaqu
assay
inhibit
almost
express
gene
detect
qrtpcr
fig
therefor
addit
influenza
virus
ppa
also
activ
virus
caus
respiratori
diseas
next
investig
inhibitori
effect
ppa
influenza
viru
life
cycl
four
differ
drug
administr
approach
includ
pretreat
cell
pretreat
viru
infect
infect
employ
describ
test
inhibitori
effect
drug
cpe
observ
microscop
use
evalu
antivir
effect
ppa
fig
quantifi
use
mtt
assay
shown
tabl
addit
ha
also
investig
surfac
glycoprotein
neuraminidas
na
possibl
target
ppa
shown
fig
ppa
notic
inhibit
na
inhibit
concentr
test
na
inhibit
assay
perform
concentr
ppa
high
percent
inhibit
activ
na
toward
substrat
still
less
sinc
viral
envelop
lipid
bilay
deriv
host
cell
membran
next
investig
interact
ppa
lipid
extract
mdck
cell
first
test
whether
ppa
bound
surfac
lipid
bilay
experi
ppa
incub
lipid
extract
mdck
cell
min
extens
rins
pb
remov
unbound
ppa
ppa
absorb
lipid
cell
extract
methanol
fluoresc
intens
subsequ
measur
excit
wavelength
nm
shown
fig
intens
fluoresc
emiss
ppa
wavelength
ca
nm
observ
lipid
extract
remain
cell
extract
remain
indic
strong
bind
affin
ppa
lipid
bilay
next
fluoresc
spectroscopi
employ
measur
interact
ppa
lipid
first
ppa
pb
mix
mgml
lipid
pb
excit
wavelength
nm
emiss
fluoresc
measur
wavelength
rang
nm
indic
fig
data
reveal
ca
increas
fluoresc
intens
assay
perform
presenc
lipid
furthermor
appar
red
shift
nm
nm
nm
maximum
emiss
wavelength
observ
lipid
ad
ppa
inspir
data
semiquantit
measur
lipidppa
interact
use
isotherm
titrat
calorimetri
itc
obtain
thermodynam
curv
bind
ppa
lipid
lipid
extract
mdck
cell
ad
concentr
mgml
concentr
ppa
thermal
chang
due
interact
ppa
cellular
lipid
detect
present
thermogram
shown
fig
itc
peak
neg
indic
interact
ppa
lipid
exotherm
base
measur
valu
ppa
interact
lipid
bilay
next
examin
effect
lipid
antiiav
activ
ppa
vitro
indic
tabl
antivir
activ
ppa
appar
reduc
addit
lipid
support
presenc
interact
ppa
lipid
antiiav
activ
ppa
assess
analyz
iavinfect
mice
experi
male
kunm
mice
averag
bodi
weight
ca
g
divid
five
group
mice
indic
fig
shown
fig
compar
viru
control
group
surviv
rate
mean
surviv
time
infect
mice
treat
high
low
dosag
ppa
notic
increas
parallel
signific
increas
lung
index
observ
viruschalleng
mice
compar
blank
control
group
addit
averag
lung
indic
compoundtr
group
lower
viru
control
group
nevertheless
signific
differ
ppah
group
ppal
group
observ
experi
fig
furthermor
bodi
weight
virusinfect
mice
decreas
eighth
ninth
day
compar
slow
increas
bodi
weight
observ
blank
control
group
bodi
weight
compoundtr
group
slowli
increas
mice
viru
control
group
die
fig
addit
histopatholog
examin
lung
mice
fig
show
compar
blank
control
group
larg
amount
alveolar
collaps
deform
around
bronchiol
occur
mani
inflammatori
cell
infiltr
observ
virusinfect
mice
contrast
symptom
dramat
allevi
compoundtr
group
fig
support
protect
effect
ppa
human
affect
global
popul
mild
sever
ill
year
current
two
type
antiiav
drug
avail
emerg
viral
strain
resist
compound
report
addit
side
effect
therefor
imper
develop
new
effect
antiiav
drug
employ
differ
mechan
target
viral
protein
cellular
factor
involv
influenza
viru
life
cycl
studi
identifi
porphyrin
deriv
pyropheophorbid
ppa
broad
antiiav
activ
vitro
ppa
isol
marin
mussel
senhousei
also
isol
abalon
structur
ppa
deriv
chlorophyl
therefor
reason
deduct
origin
sourc
ppa
might
phytoplankton
subsequ
transform
mussel
produc
ppa
shown
fig
structur
ppa
consist
porphyrin
ring
carboxyl
group
show
typic
amphipath
structur
characterist
facilit
ppa
interact
hydrophob
lipid
envelop
virion
cell
membran
block
entri
viru
carboxyl
group
connect
lipid
chain
chlorophyl
decreas
amphipath
ppa
result
decreas
antivir
activ
ppa
howev
extens
structureact
relationship
studi
conduct
support
observ
present
studi
antiiav
activ
ppa
assess
use
variou
experi
includ
cpe
rtpcr
plaqu
reduct
assay
indirect
immunofluoresc
stain
data
contrast
report
viral
entri
inhibitor
data
show
although
ppa
deriv
function
viru
entri
inhibitor
exhibit
strong
bind
affin
hemagglutinin
ha
subunit
experi
use
surfac
plasmon
reson
spr
data
shown
neg
result
hemagglutinin
inhibit
assay
hemolysi
inhibit
assay
suggest
major
target
may
ha
consequ
ppa
deriv
unabl
block
conclus
paper
identifi
porphyrin
deriv
ppa
marin
mussel
senhousei
show
broad
antiiav
activ
vitro
vivo
well
viral
strain
caus
respiratori
diseas
includ
rsv
ppa
interact
viral
lipid
bilay
alter
membraneassoci
function
therebi
inhibit
entri
envelop
virus
howev
addit
extens
experi
still
need
assess
antivir
efficaci
detail
mechan
ppa
inhibit
viru
entri
host
cell
particularli
vivo
antiiav
effect
ppa
nevertheless
known
porphyrin
group
conjug
planar
molecul
possess
broad
applic
field
biomed
scienc
due
uniqu
structur
featur
electrochem
perform
find
studi
expand
applic
porphyrin
significantli
target
essenti
compon
viru
life
cycl
use
ppa
deriv
lead
compound
believ
potent
antivir
agent
may
gener
tabl
thermodynam
paramet
interact
ppa
lipid
mdck
cell
tabl
antiinfluenza
viru
inhibit
rate
ppa
interact
lipid
mdck
cell
afterward
ad
well
mixtur
incub
anoth
h
reaction
termin
naoh
ethanol
final
excit
wavelength
nm
emiss
wavelength
nm
use
measur
result
fluoresc
mixtur
oseltamivir
phosphat
zanamivir
employ
posit
control
mortal
rate
analyz
pearson
chisquar
test
p
lung
index
infect
mice
treat
ppa
lung
index
mice
determin
viral
infect
ppa
treatment
day
data
analyz
oneway
anova
p
p
p
bodi
weight
infect
mice
record
histopatholog
chang
lung
tissu
obtain
mice
mechan
ppa
block
entri
viru
earli
stage
infect
target
ppa
may
lipid
bilay
envelop
virus
